Hippocampal Stimulation in Chronic Low Back Pain
CompletedNot applicableNCT04888494
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In this study the investigators aim to examine the effects of Transcranial Magnetic Stimulation (TMS) on hippocampal network connectivity and pain levels in individuals with chronic low back pain.
Study details
- Official title
- Enhancing Cortical-hippocampal Functional Connectivity as a Novel Means for Relieving Chronic Low Back Pain
- Conditions
- Sponsor
- Northwestern University
- Collaborators
- National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA)
- Start date
- 2021-06-25
- Primary completion
- 2022-06-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * ≥ 6 months of back pain on a daily basis; * male or female with no racial or ethnic restrictions; * 18 to 75 years old; * average back pain intensity \> 4/10 at study entry; * must be able to read, understand, and sign consent form; * generally healthy. Exclusion Criteria: * back pain with fever, chills, rheumatoid arthritis, ankylosing spondylitis, acute vertebral fractures, * history of tumor in the back; * back surgery within the past 6 months; * Chronic neurologic conditions, e.g., Parkinson's * involvement in litigation regarding back pain; * other severe medical diseases; * pregnancy; * positive urinary screen for any recreational drugs, * opioids use; * use of anticoagulants (low dose ASA allowed); * history of gastric ulcer; renal insufficiency or congestive heart failure, * contraindication to MRI, * contraindication to TMS; including history of seizure/epilepsy\* * Any medical condition that in the investigator's judgment may prevent the individual from completing the study or put the individual at undue risk; * In the judgment of the investigator, unable or unwilling to follow protocol and instructions; * Diagnosis of major depression; * Intra-axial implants (e.g. spinal cord stimulators or pumps)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04888494